{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T04:24:22Z","timestamp":1760243062898,"version":"3.37.3"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T00:00:00Z","timestamp":1555891200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["CA148062-0","UL1TR002537"],"award-info":[{"award-number":["CA148062-0","UL1TR002537"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["CA174521-01"],"award-info":[{"award-number":["CA174521-01"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1245\/s10434-019-07370-3","type":"journal-article","created":{"date-parts":[[2019,4,22]],"date-time":"2019-04-22T17:02:22Z","timestamp":1555952542000},"page":"2525-2532","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Pancreas as a Site of Metastasis or Second Primary in Patients with Small Bowel Neuroendocrine Tumors"],"prefix":"10.1245","volume":"26","author":[{"given":"Aaron T.","family":"Scott","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel","family":"Pelletier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica E.","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott K.","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kendall J.","family":"Keck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guiying","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joseph S.","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas M.","family":"O\u2019Dorisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew M.","family":"Bellizzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James R.","family":"Howe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,4,22]]},"reference":[{"issue":"10","key":"7370_CR1","doi-asserted-by":"publisher","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","volume":"3","author":"A Dasari","year":"2017","unstructured":"Dasari A, Shen C, Halperin D, et al. Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States. JAMA Oncol. 2017;3(10):1335\u201342.","journal-title":"JAMA Oncol."},{"issue":"4","key":"7370_CR2","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1002\/cncr.29099","volume":"121","author":"J Hallet","year":"2015","unstructured":"Hallet J, Law CH, Cukier M, Saskin R, Liu N, Singh S. Exploring the rising incidence of neuroendocrine tumors: a population-based analysis of epidemiology, metastatic presentation, and outcomes. Cancer. 2015;121(4):589\u201397.","journal-title":"Cancer."},{"issue":"12","key":"7370_CR3","doi-asserted-by":"publisher","first-page":"2679","DOI":"10.1002\/ijc.30400","volume":"139","author":"M Riihimaki","year":"2016","unstructured":"Riihimaki M, Hemminki A, Sundquist K, Sundquist J, Hemminki K. The epidemiology of metastases in neuroendocrine tumors. Int J Cancer. 2016;139(12):2679\u201386.","journal-title":"Int J Cancer."},{"issue":"10","key":"7370_CR4","doi-asserted-by":"publisher","first-page":"855","DOI":"10.1097\/RLU.0000000000000533","volume":"39","author":"J Kunikowska","year":"2014","unstructured":"Kunikowska J, Pawlak D, Kolasa A, Mikolajczak R, Krolicki L. A frequency and semiquantitative analysis of pathological 68Ga DOTATATE PET\/CT uptake by primary site-dependent neuroendocrine tumor metastasis. Clin Nucl Med. 2014;39(10):855\u201361.","journal-title":"Clin Nucl Med."},{"issue":"1","key":"7370_CR5","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1097\/MPA.0b013e31829f9d3d","volume":"43","author":"R Agarwal","year":"2014","unstructured":"Agarwal R, Szalkiewicz ER, Warner RR, et al. Multiple endocrine neoplasia type 1 associated with a new mutation in the menin gene and a midgut neuroendocrine tumor. Pancreas. 2014;43(1):145\u20136.","journal-title":"Pancreas."},{"key":"7370_CR6","first-page":"699","volume":"9","author":"EA Kotteas","year":"2016","unstructured":"Kotteas EA, Syrigos KN, Saif MW. Profile of capecitabine\/temozolomide combination in the treatment of well-differentiated neuroendocrine tumors. Onco Targets Ther. 2016;9:699\u2013704.","journal-title":"Onco Targets Ther."},{"issue":"6","key":"7370_CR7","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1056\/NEJMoa1003825","volume":"364","author":"E Raymond","year":"2011","unstructured":"Raymond E, Dahan L, Raoul JL, et al. Sunitinib malate for the treatment of pancreatic neuroendocrine tumors. N Engl J Med. 2011;364(6):501\u201313.","journal-title":"N Engl J Med."},{"issue":"6","key":"7370_CR8","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.surg.2006.07.033","volume":"140","author":"B Givi","year":"2006","unstructured":"Givi B, Pommier SJ, Thompson AK, Diggs BS, Pommier RF. Operative resection of primary carcinoid neoplasms in patients with liver metastases yields significantly better survival. Surgery. 2006;140(6):891\u201397 (discussion 897\u2013898).","journal-title":"Surgery"},{"key":"7370_CR9","doi-asserted-by":"publisher","DOI":"10.1097\/sla.0000000000002809","author":"A Lewis","year":"2018","unstructured":"Lewis A, Raoof M, Ituarte PHG, et al. Resection of the primary gastrointestinal neuroendocrine tumor improves survival with or without liver treatment. Ann Surg. https:\/\/doi.org\/10.1097\/sla.0000000000002809 .","journal-title":"Ann Surg"},{"issue":"10","key":"7370_CR10","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1016\/j.ejso.2017.05.016","volume":"43","author":"LM Almond","year":"2017","unstructured":"Almond LM, Hodson J, Ford SJ, et al. Role of palliative resection of the primary tumour in advanced pancreatic and small intestinal neuroendocrine tumours: a systematic review and meta-analysis. Eur J Surg Oncol. 2017;43(10):1808\u201315.","journal-title":"Eur J Surg Oncol."},{"issue":"5","key":"7370_CR11","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1097\/PAP.0b013e3182a2dc67","volume":"20","author":"AM Bellizzi","year":"2013","unstructured":"Bellizzi AM. Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry. Adv Anat Pathol. 2013;20(5):285\u2013314.","journal-title":"Adv Anat Pathol."},{"issue":"6","key":"7370_CR12","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1016\/j.surg.2014.08.008","volume":"156","author":"JE Maxwell","year":"2014","unstructured":"Maxwell JE, Sherman SK, Stashek KM, O\u2019Dorisio TM, Bellizzi AM, Howe JR. A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors. Surgery. 2014;156(6):1359\u201365 (discussion 1365\u20131356).","journal-title":"Surgery."},{"issue":"8","key":"7370_CR13","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1007\/s10585-014-9681-2","volume":"31","author":"SK Sherman","year":"2014","unstructured":"Sherman SK, Maxwell JE, Carr JC, et al. Gene expression accurately distinguishes liver metastases of small bowel and pancreas neuroendocrine tumors. Clin Exp Metastasis. 2014;31(8):935\u201344.","journal-title":"Clin Exp Metastasis."},{"issue":"Suppl 3","key":"7370_CR14","doi-asserted-by":"publisher","first-page":"S739","DOI":"10.1245\/s10434-013-3318-6","volume":"20","author":"JC Carr","year":"2013","unstructured":"Carr JC, Sherman SK, Wang D, et al. Overexpression of membrane proteins in primary and metastatic gastrointestinal neuroendocrine tumors. Ann Surg Oncol. 2013;20(Suppl 3):S739\u201346.","journal-title":"Ann Surg Oncol."},{"issue":"2","key":"7370_CR15","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1097\/PAI.0000000000000563","volume":"26","author":"TW Czeczok","year":"2018","unstructured":"Czeczok TW, Stashek KM, Maxwell JE, et al. Clusterin in neuroendocrine epithelial neoplasms: absence of expression in a well-differentiated tumor suggests a jejunoileal origin. Appl Immunohistochem Mol Morphol. 2018;26(2):94\u2013100.","journal-title":"Appl Immunohistochem Mol Morphol."},{"key":"7370_CR16","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.ijscr.2016.03.028","volume":"22","author":"T Tsunenari","year":"2016","unstructured":"Tsunenari T, Aosasa S, Ogata S, et al. Synchronous neuroendocrine tumors in both the pancreas and ileum: a case report. Int J Surg Case Rep. 2016;22:47\u201350.","journal-title":"Int J Surg Case Rep."},{"issue":"2","key":"7370_CR17","first-page":"38","volume":"43","author":"Y Masuoka","year":"2018","unstructured":"Masuoka Y, Furukawa D, Yazawa N, et al. Rectal neuroendocrine tumor with synchronous pancreatic metastasis: a case report. Tokai J Exp Clin Med. 2018;43(2):38\u201344.","journal-title":"Tokai J Exp Clin Med."},{"issue":"4","key":"7370_CR18","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.pan.2018.05.386","volume":"18","author":"AC Milanetto","year":"2018","unstructured":"Milanetto AC, Zurcher A-LG, Da Broi M, Pedrazzoli S, Pasquali C. Metastases to the pancreas from small intestinal neuroendocrine tumors [abstract no. P3-200]. Pancreatology. 2018;18(4):S143.","journal-title":"Pancreatology"},{"issue":"6","key":"7370_CR19","doi-asserted-by":"crossref","first-page":"931","DOI":"10.5858\/2008-132-931-MPOCRF","volume":"132","author":"G Disibio","year":"2008","unstructured":"Disibio G, French SW. Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med. 2008;132(6):931\u20139.","journal-title":"Arch Pathol Lab Med."},{"issue":"9","key":"7370_CR20","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1046\/j.1440-1827.2001.01258.x","volume":"51","author":"E Nakamura","year":"2001","unstructured":"Nakamura E, Shimizu M, Itoh T, Manabe T. Secondary tumors of the pancreas: clinicopathological study of 103 autopsy cases of Japanese patients. Pathol Int. 2001;51(9):686\u201390.","journal-title":"Pathol Int."},{"issue":"6","key":"7370_CR21","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1007\/s00428-004-0987-3","volume":"444","author":"NV Adsay","year":"2004","unstructured":"Adsay NV, Andea A, Basturk O, Kilinc N, Nassar H, Cheng JD. Secondary tumors of the pancreas: an analysis of a surgical and autopsy database and review of the literature. Virchows Arch. 2004;444(6):527\u201335.","journal-title":"Virchows Arch."},{"key":"7370_CR22","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ctrv.2016.01.005","volume":"44","author":"A Lamarca","year":"2016","unstructured":"Lamarca A, Elliott E, Barriuso J, et al. Chemotherapy for advanced non-pancreatic well-differentiated neuroendocrine tumours of the gastrointestinal tract, a systematic review and meta-analysis: a lost cause? Cancer Treat Rev. 2016;44:26\u201341.","journal-title":"Cancer Treat Rev."},{"issue":"4","key":"7370_CR23","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1007\/s11154-017-9432-1","volume":"18","author":"A Angelousi","year":"2017","unstructured":"Angelousi A, Kaltsas G, Koumarianou A, Weickert MO, Grossman A. Chemotherapy in NETs: when and how. Rev Endocr Metab Disord. 2017;18(4):485\u201397.","journal-title":"Rev Endocr Metab Disord."},{"issue":"4","key":"7370_CR24","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1016\/j.jamcollsurg.2016.12.032","volume":"224","author":"EA Woltering","year":"2017","unstructured":"Woltering EA, Voros BA, Beyer DT, et al. Aggressive surgical approach to the management of neuroendocrine tumors: a report of 1,000 surgical cytoreductions by a single institution. J Am Coll Surg. 2017;224(4):434\u201347.","journal-title":"J Am Coll Surg."},{"issue":"9","key":"7370_CR25","doi-asserted-by":"publisher","first-page":"2971","DOI":"10.1245\/s10434-014-3728-0","volume":"21","author":"SK Sherman","year":"2014","unstructured":"Sherman SK, Maxwell JE, O\u2019Dorisio MS, O\u2019Dorisio TM, Howe JR. Pancreastatin predicts survival in neuroendocrine tumors. Ann Surg Oncol. 2014;21(9):2971\u201380.","journal-title":"Ann Surg Oncol."},{"issue":"3","key":"7370_CR26","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1200\/JCO.2012.44.2905","volume":"31","author":"MS Khan","year":"2013","unstructured":"Khan MS, Kirkwood A, Tsigani T, et al. Circulating tumor cells as prognostic markers in neuroendocrine tumors. J Clin Oncol. 2013;31(3):365\u201372.","journal-title":"J Clin Oncol"},{"issue":"32","key":"7370_CR27","doi-asserted-by":"publisher","first-page":"4342","DOI":"10.3748\/wjg.v18.i32.4342","volume":"18","author":"A Rosales-Velderrain","year":"2012","unstructured":"Rosales-Velderrain A, Bowers SP, Goldberg RF, et al. National trends in resection of the distal pancreas. World J Gastroenterol. 2012;18(32):4342\u20139.","journal-title":"World J Gastroenterol."},{"issue":"1","key":"7370_CR28","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.jss.2010.04.017","volume":"163","author":"JK Smith","year":"2010","unstructured":"Smith JK, Ng SC, Hill JS, et al. Complications after pancreatectomy for neuroendocrine tumors: a national study. J Surg Res. 2010;163(1):63\u20138.","journal-title":"J Surg Res."},{"issue":"1","key":"7370_CR29","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1111\/hpb.12078","volume":"16","author":"J He","year":"2014","unstructured":"He J, Ahuja N, Makary MA, et al. 2564 resected periampullary adenocarcinomas at a single institution: trends over three decades. HPB (Oxford). 2014;16(1):83\u201390.","journal-title":"HPB (Oxford)."}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07370-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-07370-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07370-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,16]],"date-time":"2022-09-16T14:29:25Z","timestamp":1663338565000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-07370-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,22]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["7370"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-07370-3","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"type":"print","value":"1068-9265"},{"type":"electronic","value":"1534-4681"}],"subject":[],"published":{"date-parts":[[2019,4,22]]},"assertion":[{"value":"31 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}